Behind every cancer diagnosis, there’s a daughter, a father, a

neighbor, a friend. And with each person’s cancer, there may

be genetic clues to help identify better therapy options to

achieve better results. As a world leader in cancer genomics,

UNC Lineberger Comprehensive Cancer Center helped test

whether IBM Watson could improve how cancer experts

identify therapeutic options. By pairing a cancer’s genomic

profile with information culled

from millions of medical journals

and research studies, we

demonstrated that Watson – and

cognitive computing – could help

our team identify patient-specific

treatments, significantly reducing

the amount of time it takes to

perform this analysis.

We’re extremely proud of our extraordinary clinicians and

researchers who make it happen. And though we have a bold

vision of what the future of cancer care can be, we never lose

sight of the lives we touch every day.

We take cancer very personally.

UNC Lineberger Director Norman E. Sharpless, MD,

and Nirali Patel, MD, review a patient’s molecular

profile report generated by IBM Watson Genomics.

For more information, visit unclineberger.org/innovate